Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
No Overlap among Serum GAD65, NMDAR and AQP4 Antibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
Neuromyelitis optica antibody in Leber hereditary optic neuropathy: case report.
Oxidative Modifications of Cerebral Transthyretin are Associated with Multiple Sclerosis.
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians.
Balkans syndrome: a potential link between multiple sclerosis and hypervaccination.
The effect of group psycho-education program on the burden of family caregivers with multiple sclerosis patients in Isfahan in 2013-2014.
Expanded Disability Status Scale-Based Disability and Dental-Periodontal Conditions in Patients with Multiple Sclerosis.
IL-4/10 prevents stress vulnerability following imipramine discontinuation.
NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage.
Pregnancy and multiple sclerosis.
Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.
Multiple sclerosis-like neurological manifestations in a coeliac patient: nothing is as it seems.
Evaluation of the Effect of Progressive Relaxation Exercises on Fatigue and Sleep Quality in Patients with Multiple Sclerosis.
Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.
CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.
Head Tracking Latency in Virtual Environments Revisited: Do Users with Multiple Sclerosis Notice Latency Less?
Multiple sclerosis lesion segmentation using dictionary learning and sparse coding.
Targeting IL-10 in Auto-immune Diseases.
The complex immunology of multiple sclerosis.
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status.
Multiple sclerosis drugs: how much bang for the buck?
Pages
« first
‹ previous
…
387
388
389
390
391
392
393
394
395
…
next ›
last »